DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Fate Therapeutics, Inc. (FATE)
« Back to company indexFATE Chatter Timeline
Stock Ticker for FATE
Most Active Tweeters for FATE
No tweets foundRecent Tweets for FATE
 |
@MareaInformativ Fate Therapeutics $FATE Earning Somewhat Positive Press Coverage, Study Shows https://t.co/7b5oN743lB August 21st 2018, 9:08pm |
 |
@bibeypost_stock What's Next for Fate Therapeutics, Inc. $FATE After Forming Bullish Double Top? - https://t.co/Xp4i0uAtyE August 21st 2018, 8:08pm |
 |
@mmahotstuff1 Could Fate Therapeutics, Inc. $FATE Increase Even More? The Stock Formed Double Top Chart Pattern - https://t.co/iZjFCBquxs August 21st 2018, 8:08pm |
 |
@reurope_stock Could Fate Therapeutics, Inc. $FATE Go Up? The Stock Formed Double Top https://t.co/UXMb0uu6M2 August 21st 2018, 8:08pm |
 |
@The_CasualSmart Fate Therapeutics, Inc. $FATE on Focus After Forming Bullish Double Top Pattern https://t.co/xBHMfuIkBT August 21st 2018, 8:08pm |
 |
@west_moreland Bullish Chart Formation for Fate Therapeutics, Inc. $FATE After Forming Bullish Double Top Chart Pattern https://t.co/lENsD2qxRN August 21st 2018, 8:08pm |
|
@The_CasualSmart After Forming Bullish Double Top, Is Fate Therapeutics, Inc. $FATE's Near-Term Analysis Positive? https://t.co/GZGt8uRB1N August 21st 2018, 8:08pm |
 |
@Fanob_stock Fate Therapeutics, Inc. $FATE Could Help Your Portfolio. The Stock Formed Bullish Double Top Pattern https://t.co/pfINchbaIk August 21st 2018, 8:08pm |
 |
@TheMarketsDaily -$0.27 EPS Expected for Fate Therapeutics Inc $FATE This Quarter https://t.co/4hnNtDx5c0 August 21st 2018, 11:08am |
|
@MareaInformativ Fate Therapeutics $FATE Upgraded by BidaskClub to Buy https://t.co/9LFZe82iHv August 21st 2018, 10:08am |
 |
@registrarjourn Fate Therapeutics $FATE Cut to Hold at BidaskClub https://t.co/gNnBJRWtmQ August 21st 2018, 4:08am |
 |
@EnterpriseLeade Fate Therapeutics $FATE Cut to Hold at BidaskClub https://t.co/LrhBvRYcw1 August 21st 2018, 4:08am |
 |
@ThisLincolnian Analysts Set Fate Therapeutics Inc $FATE Target Price at $16.71 https://t.co/6DOVYb0Ta0 August 20th 2018, 11:08am |
 |
@usindexlive Copeland Capital Management Has Trimmed Its Boeing Co $BA Holding; Fate Therapeutics, Inc. $FATE Covered By 5 Bulls https://t.co/1IUsUKwOBC August 19th 2018, 8:08am |
|
@MareaInformativ Fate Therapeutics $FATE Earning Somewhat Positive Media Coverage, Study Finds https://t.co/ji7Anc5HXE August 18th 2018, 11:08pm |
|
@registrarjourn Fate Therapeutics $FATE Getting Somewhat Favorable Media Coverage, Study Shows https://t.co/VIGoVtXzzx August 18th 2018, 10:08pm |
|
@EnterpriseLeade Fate Therapeutics $FATE Getting Somewhat Favorable Media Coverage, Study Shows https://t.co/5mQRQ36dDm August 18th 2018, 10:08pm |
|
@bibeypost_stock Fate Therapeutics Inc $FATE Quarterly Sentiment Change Report - https://t.co/27OKxlYkb3 August 18th 2018, 10:08am |
|
@mmahotstuff1 Institutional Investor Sentiment About Fate Therapeutics Inc $FATE Improved - https://t.co/fErRUBw5XI August 18th 2018, 10:08am |
 |
@whatsonthorold2 Institutional Investor Sentiment About Fate Therapeutics Inc $FATE Up - https://t.co/ACCDMz7QLL August 18th 2018, 10:08am |
|
@west_moreland Institutional Investors Are Betting On Fate Therapeutics Inc $FATE https://t.co/WuEzvOn2M6 August 18th 2018, 10:08am |
|
@Fanob_stock Fate Therapeutics Inc $FATE Institutional Investors Sentiment Improved in Q1 2018 https://t.co/gcbvQPz89X August 18th 2018, 10:08am |
|
@MareaInformativ Fate Therapeutics $FATE Receives “Hold” Rating from HC Wainwright https://t.co/5ve5Khyufa August 18th 2018, 7:08am |
|
@MareaInformativ Fate Therapeutics $FATE Raised to Hold at Zacks Investment Research https://t.co/KEKUQlZT7z August 17th 2018, 12:08pm |
 |
@dakotafinancial Fate Therapeutics Inc $FATE Receives Consensus Recommendation of “Buy” from Analysts https://t.co/AV5Vo8jtZ3 August 17th 2018, 3:08am |
 |
@AmericanBanking Fate Therapeutics Inc $FATE Given Consensus Recommendation of “Buy” by Brokerages https://t.co/gBioN1xA6d #stocks August 17th 2018, 3:08am |
|
@MareaInformativ Financial Survey: Fate Therapeutics $FATE and Vical $VICL https://t.co/3Saa1rjLuk August 15th 2018, 10:08pm |
|
@registrarjourn Fate Therapeutics Inc $FATE Expected to Post Quarterly Sales of $1.27 Million https://t.co/TK2N8GyFJF August 15th 2018, 5:08am |
 |
@ChartMill Besides having an excellent technical rating, $FATE also presents a decent setup pattern. https://t.co/tH00tGbXFV https://t.co/GBVBmIHXEr August 14th 2018, 8:08pm |
|
@MareaInformativ Fate Therapeutics $FATE Announces Earnings Results, Misses Estimates By $0.05 EPS https://t.co/i4Un5C9XZB August 14th 2018, 4:08pm |
|
@registrarjourn Fate Therapeutics $FATE Earns Outperform Rating from Wedbush https://t.co/TL3VV95pKo August 14th 2018, 10:08am |
|
@MareaInformativ Fate Therapeutics $FATE Raised to “Buy” at BidaskClub https://t.co/9LFZe82iHv August 14th 2018, 7:08am |
 |
@bbnsnews Fate Therapeutics $FATE Raised to “Buy” at BidaskClub https://t.co/bDGa39MWrB August 14th 2018, 6:08am |
 |
@TickerReport Fate Therapeutics $FATE Raised to “Buy” at BidaskClub https://t.co/djdkaORpAP August 14th 2018, 3:08am |
|
@MareaInformativ Zacks Investment Research Lowers Fate Therapeutics $FATE to Sell https://t.co/yr6xZ4g42v August 14th 2018, 1:08am |
 |
@VistaPResearch RT @VistaPResearch: Fate Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference August 14 $FATE $IBB #biotech #investing… August 13th 2018, 3:08pm |
|
@VistaPResearch Fate Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference August 14 $FATE $IBB #biotech… https://t.co/NaPawWsPYP August 13th 2018, 2:08pm |
 |
@WatchlistN Fate Therapeutics $FATE Rating Increased to Buy at BidaskClub https://t.co/ktPyJwDitA August 13th 2018, 12:08pm |
|
@MareaInformativ Fate Therapeutics Inc $FATE Expected to Post Quarterly Sales of $1.27 Million https://t.co/UM6AF0qwMj August 13th 2018, 11:08am |
|
@EnterpriseLeade Fate Therapeutics $FATE Lowered to “Hold” at BidaskClub https://t.co/LrhBvRYcw1 August 13th 2018, 6:08am |
|
@ChartMill Looking at the yearly performance, $FATE did better than 98% of all other stocks. https://t.co/KA8AqYLfaC https://t.co/UE8X7tSfhK August 12th 2018, 6:08pm |
|
@MareaInformativ Brokerages Set Fate Therapeutics Inc $FATE Price Target at $16.17 https://t.co/WSeOR4J9bB August 12th 2018, 2:08pm |
|
@ThisLincolnian BidaskClub Upgrades Fate Therapeutics $FATE to “Buy” https://t.co/4vhV7WpLv9 August 12th 2018, 4:08am |
 |
@ConsumerFeed Q3 2018 EPS Estimates for Fate Therapeutics Inc Reduced by Wedbush $FATE https://t.co/2mokCrJO1l August 12th 2018, 1:08am |
|
@ConsumerFeed Fate Therapeutics $FATE Upgraded to Buy at BidaskClub https://t.co/nOWIvbfQLZ August 11th 2018, 5:08pm |
|
@TheMarketsDaily Wedbush Reiterates Outperform Rating for Fate Therapeutics $FATE https://t.co/KRqqZFAQwN August 11th 2018, 12:08pm |
|
@bbnsnews Q3 2018 Earnings Estimate for Fate Therapeutics Inc Issued By Wedbush $FATE https://t.co/aMEwvfacay August 11th 2018, 6:08am |
|
@EnterpriseLeade Somewhat Positive Press Coverage Somewhat Unlikely to Impact Fate Therapeutics $FATE Share Price https://t.co/5mQRQ36dDm August 11th 2018, 4:08am |
|
@ThisLincolnian HC Wainwright Reiterates “Hold” Rating for Fate Therapeutics $FATE https://t.co/zLmldkIHuX August 11th 2018, 4:08am |
|
@TheMarketsDaily Fate Therapeutics $FATE Earns Hold Rating from HC Wainwright https://t.co/WcvPUU08OD August 10th 2018, 5:08pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2018. All rights reserved.